General information

Name:

Betalinuk Ltd

Office Address:

The Nexus Building Discovery Way LS2 3AA Leeds

Number: 12808561

Incorporation date: 2020-08-12

End of financial year: 31 December

Category: Private Limited Company

Status: Active

Description

Data updated on:

Betalinuk Limited with the registration number 12808561 has been in this business field for 4 years. This particular Private Limited Company can be reached at The Nexus Building, Discovery Way in Leeds and its zip code is LS2 3AA. This enterprise's classified under the NACE and SIC code 72110 - Research and experimental development on biotechnology. Betalinuk Ltd released its latest accounts for the period that ended on 2021-12-31. The business latest annual confirmation statement was submitted on 2023-08-11.

The company has 1 director presently supervising the following business, specifically Yehosua H. who's been performing the director's responsibilities for 4 years. That business had been directed by Rahel O. up until March 11, 2024. Furthermore another director, namely Nikolai K. resigned one year ago.

Financial data based on annual reports

Company staff

Yehosua H.

Role: Director

Appointed: 11 March 2024

Latest update: 11 April 2024

Accounts Documents

Account next due date 30 September 2023
Account last made up date 31 December 2021
Confirmation statement next due date 25 August 2024
Confirmation statement last made up date 11 August 2023
Annual Accounts
Start Date For Period Covered By Report 2020-08-12
End Date For Period Covered By Report 2021-12-31
Annual Accounts
Start Date For Period Covered By Report 2022-01-01
End Date For Period Covered By Report 2022-12-31

Company filings

Filing category

Hide filing type
Accounts Address Confirmation statement Gazette Incorporation Officers
Free Download
Compulsory strike-off action has been discontinued (DISS40)
filed on: 3rd, April 2024
gazette
Free Download Download filing (1 page)

Search other companies

Services (by SIC Code)

  • 72110 : Research and experimental development on biotechnology
3
Company Age